NUVOV Trademark

Trademark Overview

On Monday, June 1, 2015, a trademark application was filed for NUVOV with the United States Patent and Trademark Office. The USPTO has given the NUVOV trademark a serial number of 86647412. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 17, 2025. This trademark is owned by Glaxo Group Limited. The NUVOV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
nuvov

General Information

Serial Number86647412
Word MarkNUVOV
Filing DateMonday, June 1, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 17, 2025
Registration Number5505713
Registration DateTuesday, July 3, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, June 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 4, 2015NEW APPLICATION ENTERED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 8, 2015ASSIGNED TO EXAMINER
Tuesday, September 15, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 30, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 20, 2015PUBLISHED FOR OPPOSITION
Tuesday, October 20, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, November 6, 2015EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, December 21, 2015EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 27, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, July 27, 2016SOU EXTENSION 1 FILED
Wednesday, July 27, 2016SOU EXTENSION 1 GRANTED
Friday, July 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 25, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, January 25, 2017SOU EXTENSION 2 FILED
Wednesday, January 25, 2017SOU EXTENSION 2 GRANTED
Friday, January 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 13, 2017SOU TEAS EXTENSION RECEIVED
Thursday, July 13, 2017SOU EXTENSION 3 GRANTED
Thursday, July 13, 2017SOU EXTENSION 3 FILED
Saturday, July 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2018SOU TEAS EXTENSION RECEIVED
Thursday, February 8, 2018SOU EXTENSION 4 FILED
Thursday, February 8, 2018SOU EXTENSION 4 GRANTED
Saturday, February 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 19, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, March 8, 2018ASSIGNED TO PETITION STAFF
Friday, March 9, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, March 9, 2018ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Thursday, March 15, 2018NOTICE OF ALLOWANCE CANCELLED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 3, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 17, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

nuvov pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological